Durham drug startup to target variety of therapies with $155M in new funding
Brii Biosciences is plowing ahead with its clinical development programs after landing a whooping $155 million in funding. We’ve got the details.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
